A study on 3D hologram with mixed reality techniques for better understanding the pulmonary lesions of COVID-19

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100045845

Enrollment

Unknown

Registered

2021-04-25

Start date

2021-04-25

Completion date

Unknown

Last updated

2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Group A:Conventional 2-D CT of COVID-19 lung was observed

Group B:Three - dimensional lung hologram of COVID-19 was observed

Eligibility

Sex/Gender

Male

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Lung CT data of 6 patients with mild to severe COVID-19 were selected; 2. Surgeons and medical students not specifically trained in COVID-19 lung CT imaging.

Exclusion criteria

Exclusion criteria: Participants had previously seen 3D holograms of COVID-19 lungs.

Design outcomes

Primary

Measure	Time frame
Performance score;Likert-scale questionnaire;NASA Task Load Index;	—

Countries

China

Contacts

Public ContactYe Zhewei

Union Hospital, Tongji Medical College, Huazhong University of Science & Technology

yezhewei@hust.edu.cn+86 13971213880

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026